The DOI matches its Crossref record; 137 of the 140 references it cites were found in a registry or an index.
Poly(ADP-ribose) signaling in cell death
Open accessAbstract
Poly(ADP-ribosyl)ation (PARylation) is a reversible protein modification carried out by the concerted actions of poly(ADP-ribose) polymerase (PARP) enzymes and poly(ADP-ribose) (PAR) decomposing enzymes such as PAR glycohydrolase (PARG) and ADP-ribosyl hydrolase 3 (ARH3). Reversible PARylation is a pleiotropic regulator of various cellular functions but uncontrolled PARP activation may also lead to cell death. The cellular demise pathway mediated by PARylation in oxidatively stressed cells has been described almost thirty years ago. However, the underlying molecular mechanisms have only begun to emerge relatively recently. PARylation has been implicated in necroptosis, autophagic cell death but its role in extrinsic and intrinsic apoptosis appears to be less predominant and depends largely on the cellular model used. Currently, three major pathways have been made responsible for PARP-mediated necroptotic cell death: (1) compromised cellular energetics mainly due to depletion of NAD, the substrate of PARPs; (2) PAR mediated translocation of apoptosis inducing factor (AIF) from mitochondria to nucleus (parthanatos) and (3) a mostly elusive crosstalk between PARylation and cell death/survival kinases and phosphatases. Here we review how these PARP-mediated necroptotic pathways are intertwined, how PARylation may contribute to extrinsic and intrinsic apoptosis and discuss recent developments on the role of PARylation in autophagy and autophagic cell death.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“parthanatos appears to occur not only as a consequence of severe/prolonged alkylating DNA damage, but also in response to oxidative stress, hypoxia, hypoglycemia, or inflammatory cues [656–658].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [657]
Citations
Cites
Autophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069
Autophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Molecular characterization of mitochondrial apoptosis-inducing factor
Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., et al. (1999) · Nature · doi:10.1038/17135 · Cited by 4,060
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Autophagy and the Integrated Stress Response
Kroemer, G., Mariño, G., & Levine, B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.023 · Cited by 3,506
Kim, D., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument‐Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 3,051
The role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
Galluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., Dawson, T. M., Dawson, V. L., El-Deiry, W. S., Fulda, S., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.96 · Cited by 2,421
Cited by
Sorted by citations
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Regulated necrosis: the expanding network of non-apoptotic cell death pathways
Berghe, T. V., Linkermann, A., Jouan-Lanhouet, S., Walczak, H., & Vandenabeele, P. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3737 · Cited by 1,735
DNA damage and the balance between survival and death in cancer biology
Roos, W. P., Thomas, A. D., & Kaina, B. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.2 · Cited by 1,189
Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications
Tuo, Q., Zhang, S., & Lei, P. (2021) · Medicinal Research Reviews · doi:10.1002/med.21817 · Cited by 771
Regulated necrosis: disease relevance and therapeutic opportunities
Conrad, M., Angeli, J. P. F., Vandenabeele, P., & Stockwell, B. R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.6 · Cited by 630
Quantitative Analysis of NAD Synthesis-Breakdown Fluxes
Liu, L., Su, X., Quinn, W. J., Hui, S., Krukenberg, K., Frederick, D. W., Redpath, P., Zhan, L., Chellappa, K., White, E., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.018 · Cited by 564
Poly(ADP-ribose) polymerase inhibition: past, present and future
Curtin, N. J., & Szabó, C. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0076-6 · Cited by 595
A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1
Wang, Y., An, R., Umanah, G. K., Park, H., Nambiar, K., Eacker, S. M., Kim, B., Bao, L., Harraz, M. M., Chang, C., et al. (2016) · Science · doi:10.1126/science.aad6872 · Cited by 421
“Consistent with the idea that PARP-1 is a key cell-deathmediator, PARP inhibitors or genetic deletion of PARP-1 protect against such cellular injury in models of human disease (2, 4, 5, 7).”
BackgroundMitochondrial dysfunction in neurodegenerative disorders
Klemmensen, M. M., Borrowman, S. H., Pearce, C., Pyles, B., & Chandra, B. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2023.10.002 · Cited by 396
Regulated necrosis in kidney ischemia-reperfusion injury
Pefanis, A., Ierino, F. L., Murphy, J. M., & Cowan, P. J. (2019) · Kidney International · doi:10.1016/j.kint.2019.02.009 · Cited by 361
PARP-1 and its associated nucleases in DNA damage response
Wang, Y., Luo, W., & Wang, Y. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.102651 · Cited by 279
Cell death mechanisms in eukaryotes
Nirmala, J. G., & Lopus, M. (2019) · Cell Biology and Toxicology · doi:10.1007/s10565-019-09496-2 · Cited by 279
“Hyperactivation of PARP1 in response to extreme genomic stress, hypoxia, and hypoglycemia leads to ATP depletion, triggering parthanatos (Virág et al. 2013).”
BackgroundCisplatin crosslinked pH-sensitive nanoparticles for efficient delivery of doxorubicin
Li, M., Tang, Z., Lv, S., Song, W., Hong, H., Jing, X., Zhang, Y., & Chen, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.018 · Cited by 262
“To further confirm the tumor apoptosis, the cleaved 25 kDa fragment of PARP1, one of the essential substrates cleaved by both caspase-3 and -7 [30,56], was analyzed in the tumor sections by immunohistochemistry.”
MethodLüscher, B., Bütepage, M., Eckei, L., Krieg, S., Verheugd, P., & Shilton, B. H. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00122 · Cited by 264
Beyond DNA Repair: Additional Functions of PARP-1 in Cancer
Weaver, A. N., & Yang, E. S. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00290 · Cited by 246
The role of poly ADP-ribosylation in the first wave of DNA damage response
Liu, C., Vyas, A., Kassab, M. A., Singh, A. K., & Yu, X. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx565 · Cited by 245
Nuclear ADP-Ribosylation and Its Role in Chromatin Plasticity, Cell Differentiation, and Epigenetics
Hottiger, M. O. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-034506 · Cited by 231
Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases
Berger, N. A., Besson, V. C., Boulares, A. H., Bürkle, A., Chiarugi, A., Clark, R. S. B., Curtin, N. J., Cuzzocrea, S., Dawson, T. M., Dawson, V. L., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13748 · Cited by 219
“The PARP-mediated active form of cell death has been reviewed, in detail, in recent articles (Virág and Szabo, 2002; Virág et al., 2013; Baxter et al., 2014; Fatokun et al., 2014).”
Poly(ADP-ribose): PARadigms and PARadoxes
Bürkle, A., & Virág, L. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.12.010 · Cited by 205
“NAD + depletion and acute cell death ((Virág and Szabo, 2002) and Virág et al., 2013).”
BackgroundSelf-citationMolecular Mechanisms of Parthanatos and Its Role in Diverse Diseases
Huang, P., Chen, G., Jin, W., Mao, K., Wan, H., & He, Y. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137292 · Cited by 200
Targeting Programmed Cell Death Using Small‐Molecule Compounds to Improve Potential Cancer Therapy
Ke, B., Tian, M., Li, J., Liu, B., & He, G. (2016) · Medicinal Research Reviews · doi:10.1002/med.21398 · Cited by 190
PARPs in lipid metabolism and related diseases
Szántó, M., Gupte, R., Kraus, W. L., Pacher, P., & Bai, P. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101117 · Cited by 181
Ruozi, B., Belletti, D., Pederzoli, F., Masoni, M., Keller, J., Ballestrazzi, A., Vandelli, M. A., Tosi, G., & Grabrucker, A. M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.05.015 · Cited by 184
“Thus, the amount of cleaved PARP is indicative of programmed cell death (Virág et al., 2013).”
BackgroundAtasheva, S., Frolova, E. I., & Frolov, I. V. (2013) · Journal of Virology · doi:10.1128/jvi.03443-13 · Cited by 186
Henning, R. J., Bourgeois, M., & Harbison, R. D. (2018) · Cardiovascular Toxicology · doi:10.1007/s12012-018-9462-2 · Cited by 158
“This process permits maintenance of cellular ATP that is essential for myocyte or endothelial cell apoptosis [15, 16].”
BackgroundNew Facets in the Regulation of Gene Expression by ADP-Ribosylation and Poly(ADP-ribose) Polymerases
Ryu, K. W., Kim, D.-S., & Kraus, W. L. (2015) · Chemical Reviews · doi:10.1021/cr5004248 · Cited by 151
James, D. I., Smith, K. M., Jordan, A. M., Fairweather, E. E., Griffiths, L. A., Hamilton, N. S., Hitchin, J. R., Hutton, C. P., Jones, S. D., Kelly, P. J., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00609 · Cited by 143
Bauman, D. E., Eisemann, J. H., & Currie, W. B. (1982) · PubMed · Cited by 140
Jain, P. G., & Patel, B. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.024 · Cited by 142
Redox control of cancer cell destruction
Hegedűs, C., Kovács, K. É., Polgár, Z., Regdon, Z., Szabó, É., Robaszkiewicz, A., Forman, H. J., Martner, A., & Virág, L. (2018) · Redox Biology · doi:10.1016/j.redox.2018.01.015 · Cited by 142
Self-citationWu, J., Ye, J., Kong, W., Zhang, S., & Zheng, Y. (2020) · Cell Proliferation · doi:10.1111/cpr.12915 · Cited by 137
Pathophysiological role of different tubular epithelial cell death modes in acute kidney injury
Sancho-Martínez, S. M., López-Novoa, J. M., & López-Hernández, F. J. (2015) · Clinical Kidney Journal · doi:10.1093/ckj/sfv069 · Cited by 130
Zhang, N., Zhang, Y., Qian, H. R., Wu, S., Cao, L., & Sun, Y. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0523-2 · Cited by 127
Exosomes in skin photoaging: biological functions and therapeutic opportunity
Najafabadi, A. H., Soheilifar, M. H., & Masoudi-Khoram, N. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01451-3 · Cited by 133
“Subsequently, activated PARP-1 can induce DNA repair through a base excision repair [28, 29].”
BackgroundThe recognition and removal of cellular poly( ADP ‐ribose) signals
Barkauskaite, E., Jankevicius, G., Ladurner, A. G., Ahel, I., & Timinszky, G. (2013) · FEBS Journal · doi:10.1111/febs.12358 · Cited by 130
Imaging of neurosphere oxygenation with phosphorescent probes
Dmitriev, R. I., Zhdanov, A. V., Nolan, Y. M., & Papkovsky, D. B. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.065 · Cited by 117
“4C), while decreased levels of the apoptotic marker PARP [63] were observed in H-neurospheres suggesting improved viability of their cells.”
BackgroundZhou, X., Hong, T., Yu, Q., Nie, S., Gong, D., Xiong, T., & Xie, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-14178-2 · Cited by 122
RetractedPredictive biomarkers for cancer therapy with PARP inhibitors
Michels, J., Vitale, I., Saparbaev, M. K., Castedo, M., & Kroemer, G. (2013) · Oncogene · doi:10.1038/onc.2013.352 · Cited by 117
Cell Death Mechanisms of Neurodegeneration
Fan, J., Dawson, T. M., & Dawson, V. L. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-57193-5_16 · Cited by 116
Poly(ADP-ribose): A signaling molecule in different paradigms of cell death
Aredia, F., & Scovassi, A. I. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.06.021 · Cited by 112
“The common feature of the involvement of poly(ADP-ribosylation) in different paradigms of cell death is represented by PAR [81], which can drive cells into diverse (and sometimes opposite) manners to die [77,78,82–84].”
BackgroundAn overview of ferroptosis in non-alcoholic fatty liver disease
Wang, S., Liu, Z., Geng, J., Li, L., & Feng, X. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113374 · Cited by 107
PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington’s Disease
Cardinale, A., Paldino, E., Giampà, C., Bernardi, G., & Fusco, F. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134482 · Cited by 105
“Apoptosis gives rise to the removal of damaged or unnecessary cells, and this phenomenon occurs physiologically during development or after DNA damage and normal tissue homeostasis [7, 8, 9].”
BackgroundDifferent modalities of host cell death and their impact on Mycobacterium tuberculosis infection
Nisa, A., Kipper, F. C., Panigrahy, D., Tiwari, S., Kupz, A., & Subbian, S. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00246.2022 · Cited by 102
Poly(ADP-ribosyl)ation in regulation of chromatin structure and the DNA damage response
Tallis, M., Morra, R., Barkauskaite, E., & Ahel, I. (2013) · Chromosoma · doi:10.1007/s00412-013-0442-9 · Cited by 100
“Poly(ADP-ribose) (PAR) is a dynamic and abundant posttranslational modification, with a wide array of nuclear and cytoplasmic functions in fundamental biological processes such as transcription, replication, cell cycle progression and division, ageing, intracellular transport and apoptosis/necrosis (Abd Elmageed et al…”
BackgroundMoore, Z., Chakrabarti, G., Luo, X., Ali, A., Hu, Z., Fattah, F. J., Vemireddy, R., DeBerardinis, R. J., Brekken, R. A., & Boothman, D. A. (2015) · Cell Death and Disease · doi:10.1038/cddis.2014.564 · Cited by 89
“, MNNG exposure) of PARP1 hyperactivation-mediated cell death, we sought to define the distinct contributions of PARP1 activity and PAR formation in the synergy noted with FK866+β-lap combination treatment.(26) β-Lap and FK866 combination treatment of NQO1+ MiaPaca2 or AsPC1 cells resulted in virtually undetectable PA…”
BackgroundTo translate, or not to translate: viral and host mRNA regulation by interferon-stimulated genes
Li, M. M. H., MacDonald, M. R., & Rice, C. M. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.02.001 · Cited by 92
Ceramide in the Molecular Mechanisms of Neuronal Cell Death. The Role of Sphingosine-1-Phosphate
Czubowicz, K., & Strosznajder, R. P. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8606-4 · Cited by 91
“histones, DNA polymerases and PARP-1 itself [21, 56–59].”
BackgroundBcl-xL acts as an inhibitor of IP3R channels, thereby antagonizing Ca2+-driven apoptosis
Rosa, N., Ivanova, H., Wagner, L. E., Kale, J., Rovere, R. L., Welkenhuyzen, K., Louros, N. N., Spyridoula Karamanou, A., Shabardina, V., Lemmens, I. H., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00894-w · Cited by 88
“In contrast, Bcl-xLK87D overexpression was much less effective than wild-type Bcl-xL in suppressing PARP cleavage in wild-type HeLa cells (Fig.”
BackgroundInfluentialLi, C., Sun, L., & Pang, C. (2015) · Scientific Reports · doi:10.1038/srep09819 · Cited by 83
Narne, P., Pandey, V., Simhadri, P. K., & Phanithi, P. B. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.11.007 · Cited by 80
Kanev, P.-B., Atemin, A., Stoynov, S., & Aleksandrov, R. (2023) · Seminars in Oncology · doi:10.1053/j.seminoncol.2023.08.001 · Cited by 89
PARP inhibitors: polypharmacology versus selective inhibition
Ekblad, T., Camaioni, E., Schuler, H., & Macchiarulo, A. (2013) · FEBS Journal · doi:10.1111/febs.12298 · Cited by 82
Parthanatos in the pathogenesis of nervous system diseases
Wang, X., & Ge, P. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.09.049 · Cited by 75
Agathanggelou, A., Smith, E., Davies, N. J., Kwok, M., Zlatanou, A., Oldreive, C. E., Mao, J., Da Costa, D., Yadollahi, S., Perry, T., et al. (2017) · Blood · doi:10.1182/blood-2016-12-758219 · Cited by 75
“This work was supported grants from Bloodwise, UK, (11045) (T.S.) and Worldwide Cancer Research (13-1012) (G.S.S.).”
Roles of N-Methyl-D-Aspartate Receptors (NMDARs) in Epilepsy
Chen, S., Xu, D., Liu, F., Fang, Z. H., Wang, X., & Li, M. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.797253 · Cited by 75
NAD+ Homeostasis and NAD+-Consuming Enzymes: Implications for Vascular Health
Campagna, R., & Vignini, A. (2023) · Antioxidants · doi:10.3390/antiox12020376 · Cited by 76
The PARP Enzyme Family and the Hallmarks of Cancer Part 1. Cell Intrinsic Hallmarks
Demény, M. Á., & Virág, L. (2021) · Cancers · doi:10.3390/cancers13092042 · Cited by 76
Self-citationDugbartey, G. J. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09261-7 · Cited by 77
“…of the DNA repair enzyme poly(adenosine diphosphate-ribose) polymerase-1 (PARP-1; the first member of the PARP superfamily) by a variety of pathological stimuli such as ROS, alkylating agents, calpain, increased Ca 2+ concentration, increased mitochondrial permeability and DNA damage [98, 99].”
Jiang, H., Yang, Y., Zhang, Y., Xie, Z., Zhao, X., Sun, Y., & Kong, W. (2017) · Redox Biology · doi:10.1016/j.redox.2017.10.002 · Cited by 69
Non-Apoptotic Cell Death Signaling Pathways in Melanoma
Hartman, M. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082980 · Cited by 66
Luo, X., Wang, J., Wei, X., Wang, S., & Wang, A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117019 · Cited by 65
Poly(ADP-ribose) polymerase activity and inhibition in cancer
Dulaney, C. R., Marcrom, S., Stanley, J. A., & Yang, E. S.-H. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.01.007 · Cited by 66
Genomic instability and metabolism in cancer
Li, H., Zimmerman, S. E., & Weyemi, U. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.05.004 · Cited by 64
Martí, J. M., García-Díaz, Á., Delgado‐Bellido, D., O’Valle, F., González-Flores, A., Carlevaris, O., Rodríguez-Vargas, J. M., Amé, J., Dantzer, F., King, G. L., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101885 · Cited by 64
“Through PARylation, PARPs regulate a wide array of cellular processes, including genomic instability and survival [19], chromatin organization [20], protein degradation via proteasome [21], RNA metabolism [22] and cell death [23,24].”
BackgroundSelf-citationInputs and outputs of poly(ADP-ribosyl)ation: Relevance to oxidative stress
Hegedűs, C., & Virág, L. (2014) · Redox Biology · doi:10.1016/j.redox.2014.08.003 · Cited by 63
Self-citationMorotomi‐Yano, K., Akiyama, H., & Yano, K. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.05.020 · Cited by 62
Targeting ferroptosis in ischemia/reperfusion renal injury
Thapa, K., Singh, T. G., & Kaur, A. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02277-5 · Cited by 64
Rueda, C. B., Traba, J., Amigo, I., Llorente‐Folch, I., González‐Sánchez, P., Pardo, B., Esteban, J. A., del Arco, A., & Satrústegui, J. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2702-14.2015 · Cited by 62
PARP1 and Poly(ADP-ribosyl)ation Signaling during Autophagy in Response to Nutrient Deprivation
Rodríguez-Vargas, J. M., Oliver, F. J., & Dantzer, F. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2641712 · Cited by 63
“The suicidal over-PARylation disrupts mitochondrial energy mechanisms, impairing the antioxidant capacity of the Krebs cycle and favoring the liberation of proapoptotic mitochondrial factors [20].”
BackgroundSelf-citationRegdon, Z., Robaszkiewicz, A., Kovács, K., Rygielska, Ż., Hegedűs, C., Bodoor, K., Szabó, É., & Virág, L. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.11.034 · Cited by 59
Self-citationLucarini, L., Durante, M., Lanzi, C., Pini, A., Boccalini, G., Calosi, L., Moroni, F., Masini, E., & Mannaioni, G. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12967 · Cited by 57
Liquid-liquid phase separation in DNA double-strand breaks repair
Wang, Y., Zhao, W.-W., Shi, J., Wan, X., Zheng, J., & Fan, X. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06267-0 · Cited by 62
“The major enzyme catalyzing this reaction is PAR polymerase 1 (PARP1) [95], which regulates a number of biological processes including DNA repair [96, 97], carcinogenesis [98, 99], metabolism [100, 101] signaling [102, 103], gene transcription [104, 105] and cell death [105, 106].”
BackgroundMa, J., Gao, S., Yang, H., Wang, M., Cheng, B., Feng, Z., & Wang, L. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00369 · Cited by 56
“MAPK/ERK signaling can be either pro- or anti-apoptotic depending on types of cells and insults (Wang et al., 2010).”
BackgroundNakajima, H., Kubo, T., Ihara, H., Hikida, T., Danjo, T., Nakatsuji, M., Shahani, N., Itakura, M., Ono, Y., Azuma, Y., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.635607 · Cited by 55
“A recent review postulated that PARP-1 binding to DNA strand breaks is not the only mechanism for PARP-1 activation; protein-protein interactions are also considered to be involved (8).”
BackgroundZhou, P., Hu, W., Zhang, X., Wang, W., & Zhang, L. (2016) · Mediators of Inflammation · doi:10.1155/2016/7201549 · Cited by 55
“PARP activity is well known to increase with oxidative stress, which can lead to cellular dysfunction and necrosis [46].”
BackgroundJin, X., Jin, W., Tong, L., Zhao, J., Zhang, L., & Lin, N. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.04.020 · Cited by 57
“Under normal physiological conditions, moderate activation of PARP-1 is essential for sensing and modulating stress for DNA repair 380 .”
InfluentialRole of PARP-1 in mitochondrial homeostasis
Kadam, A. A., Jubin, T., Roychowdhury, R., & Begum, R. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129669 · Cited by 55
Lontay, B., Kiss, A., Virág, L., & Tar, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124282 · Cited by 55
Self-citationTempka, D., Tokarz, P., Chmielewska, K., Kluska, M., Pietrzak, J., Rygielska, Z., Virág, L., & Robaszkiewicz, A. (2017) · Redox Biology · doi:10.1016/j.redox.2017.12.017 · Cited by 50
“However, stimuli applied in our current study caused less severe, repairable DNA damage [25,26].”
BackgroundSelf-citationThe potential regulatory roles of NAD+ and its metabolism in autophagy
Zhang, D., Zhang, J.-P., Hu, J., & Huang, Y. (2015) · Metabolism · doi:10.1016/j.metabol.2015.11.010 · Cited by 50
Regulated Cell Death Seen through the Lens of Islet Transplantation
Bruni, A. D. C., Bornstein, S. R., Linkermann, A., & Shapiro, A. M. J. (2018) · Cell Transplantation · doi:10.1177/0963689718766323 · Cited by 48
A Double-Edged Sword: The Two Faces of PARylation
Kang, M., Park, S., Park, S., Lee, H. G., & Park, J. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179826 · Cited by 48
Analysis of Chromatin ADP-Ribosylation at the Genome-wide Level and at Specific Loci by ADPr-ChAP
Bartolomei, G., Leutert, M., Manzo, M., Baubec, T., & Hottiger, M. O. (2016) · Molecular Cell · doi:10.1016/j.molcel.2015.12.025 · Cited by 54
“…repair, telomere maintenance, gene transcription, chromatin architecture, proteasomal functions, cell morphology, cell viability, cell cycle, and cell death (reviewed in Gibson and Kraus, 2012; Hassa et al., 2006; Kraus and Hottiger, 2013; Leung, 2014; Schreiber et al., 2006; Virág et al., 2013).”
BackgroundShen, K., Feng, X., Su, R., Xie, H., Zhou, L., & Zheng, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126278 · Cited by 46
Gerace, E., Masi, A., Resta, F., Felici, R., Landucci, E., Mello, T., Pellegrini-Giampietro, D. E., Mannaioni, G., & Moroni, F. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.023 · Cited by 45
Wu, H., Li, Y., Zhang, Q., Wang, H., Xiu, W., Xu, P., Deng, Y., Huang, W., & Wang, D. O. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05581-x · Cited by 43
“One possibility is that crocetin inhibits PKCζ phosphorylation, and another possibility is crocetin suppresses PI3K, which activates PKCζ [47] or decreases Ca influx, which acts upstream of PARP-1 activation and DNA damage [48].”
BackgroundAntioxidant effects of Cirsium setidens extract on oxidative stress in human mesenchymal stem cells
Lee, J. H., Jung, H. K., Han, Y., Yoon, Y. M., Yun, C. W., Sun, H. Y., Cho, H. W., & Lee, S. H. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5706 · Cited by 42
“The cleavage of PARP-1 by caspases is one of the first biochemical markers of apoptosis (26).”
Diani-Moore, S., Shoots, J., Singh, R., Zuk, J. B., & Rifkind, A. B. (2017) · Scientific Reports · doi:10.1038/s41598-017-02332-9 · Cited by 42
Cell death in animal development
Ghose, P., & Shaham, S. (2020) · Development · doi:10.1242/dev.191882 · Cited by 42
Li, M., Tang, Z., Lin, J., Zhang, Y. X., Lv, S., Song, W., Huang, Y., & Chen, X. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400108 · Cited by 40
Ruiz, P. D., Hamilton, G. A., Park, J. W., & Gamble, M. J. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00230-19 · Cited by 41
“For 49 example, translocation of protein-free PAR chains from the nucleus to mitochondria 50 triggers parthanatos, a process in which Apoptosis Inducing Factor (AIF) is released from 51 the mitochondria in response to PAR, translocates to the nucleus and initiates a form of 52 caspase-independent apoptosis (8).”
BackgroundCaspase-Independent Regulated Necrosis Pathways as Potential Targets in Cancer Management
Lou, J., Zhou, Y., Feng, Z., Ma, M., Yao, Y., Wang, Y., Deng, Y., & Wu, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.616952 · Cited by 39
“Then, NAD and ATP depletion cause energy depletion, which brings about cell death (77, 78, 82).”
BackgroundLi, X., Yang, W., & Jiang, L. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00414 · Cited by 39
“However, it is also well recognized that prolonged activation or hyperactivation of PARP-1 induces cell death, including neurotoxicity (Cole and Perez-Polo, 2002; Lo et al., 2003; Alano et al., 2010; Virág et al., 2013).”
BackgroundBrunyánszki, A., Oláh, G., Coletta, C., Szczęsny, B., & Szabó, C. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.094318 · Cited by 39
“Several lines of studies emphasize the independent causative roles of early mitochondrial events in the pathogenesis of subsequent cell death response (Tann et al., 2011; Guicciardi et al., 2013; Virag et al., 2013; Dorn, 2013).”
BackgroundWu, X., Deng, G., Li, M., Li, Y., Ma, C., Wang, Y., & Liu, X. (2015) · BMC Immunology · doi:10.1186/s12865-015-0080-5 · Cited by 37
Gerő, D., Szoleczky, P., Chatzianastasiou, A., Papapetropoulos, A., & Szabó, C. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00102 · Cited by 38
Belletti, D., Grabrucker, A. M., Pederzoli, F., Menrath, I., Vandelli, M. A., Tosi, G., Duskey, J. T., Forni, F., & Ruozi, B. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.03.061 · Cited by 37
Zheng, Q., Zhu, T., Hu, H. Z., Zhao, Y., Ying, Y., Luo, X., Ling, Y., Chen, Z., Ji, H., & Jiang, P. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.11.018 · Cited by 37
Ördög, K., Horváth, O., Erős, K., Bruszt, K., Toth, S., Kovács, D., Kálmán, N., Radnai, B., Deres, L., Gallyas, F., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118936 · Cited by 36
Yoon, J. W., Ryu, S., Lee, S., & Choi, C. (2015) · Scientific Reports · doi:10.1038/srep08231 · Cited by 35
Metadata
- Authors
- Virág, L., Robaszkiewicz, A., Rodriguez-Vargas, J. M., & Oliver, F. J.
- Affiliations
- University of Debrecen (HU)
- Instituto de Parasitología y Biomedicina "López - Neyra" (ES)
- Corresponding author
- Virág, László
- Oliver, Francisco Javier
- Venue
- Molecular Aspects of Medicine
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 34
- Issue
- 6
- Pages
- 1153-1167
- ISSN
- 0098-2997 (ISSN-L)
- OpenAlex
- W2076542944
- Cited by
- 273
- References
- 140
- Citations by year
- 2026: 8 · 2025: 20 · 2024: 15 · 2023: 17 · 2022: 23 · 2021: 21 · 2020: 21 · 2019: 20 · 2018: 14 · 2017: 23 · 2016: 29 · 2015: 26 · 2014: 22 · 2013: 13
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Molecular Aspects of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by-nc-nd)
- University of Debrecen Electronic Archive (University of Debrecen) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- poly(ADP-ribose) polymerase, necroptosis, parthanatos, apoptosis, autophagic cell death, NAD+ depletion, apoptosis-inducing factor, oxidative stress, cell death signaling
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Mitochondria, Poly Adenosine Diphosphate Ribose, Poly(ADP-ribose) Polymerases, Protein Binding, Protein Processing, Post-Translational, Signal Transduction, Cell Death, Gene Regulatory Networks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review